# China Pharma Holdings, Inc. Comments on Unusual Market Activity

- Link: https://www.thailand-business-news.com/pr-news/china-pharma-holdings-inc-comments-on-unusual-market-activity
- Published: 2026-07-22T03:00:00+07:00
- Author: PR Newswire

HAIKOU, China, July 22, 2026 /PRNewswire/ — China Pharma Holdings, Inc. (NYSE American:
CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals
company in China, today announced that, in view of the unusual market activity in
the common stock of China Pharma on July 21, 2026, the NYSE American has contacted
the Company in accordance with its usual practice. The Company stated that, while
its policy generally is not to comment on unusual market activity, it issued this
statement under Section 401(d) of the NYSE American Company Guide that it was not
aware of any material corporate developments that would explain the recent market
activity. Shareholders and prospective investors are cautioned to exercise care 
when evaluating the Company’s securities in light of the recent volatility and to
rely only on information contained in the Company’s filings with the U.S. Securities
and Exchange Commission and the Company’s press releases.

**About China Pharma Holdings, Inc. **

China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops,
manufactures and markets a diversified portfolio of products focused on conditions
with a high incidence and high mortality rates in China, including cardiovascular,
CNS, infectious, and digestive diseases. The Company’s cost-effective, high-margin
business model is driven by market demand and supported by eight scalable GMP-certified
product lines covering the major dosage forms. In addition, the Company has a broad
and expanding nationwide distribution network across all major cities and provinces
in China. The Company’s wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology
Co., Ltd., is located in Haikou City, Hainan Province. For more information about
China Pharma Holdings, Inc., please visit [http://www.chinapharmaholdings.com](http://www.chinapharmaholdings.com).
The Company routinely posts important information on its website.

**Safe Harbor Statement** 

Certain statements in this press release constitute forward-looking statements for
purposes of the safe harbor provisions under The Private Securities Litigation Reform
Act of 1995. Any statements set forth above that are not historical facts are forward-
looking statements that involve risks and uncertainties that could cause actual 
results to differ materially from those in the forward-looking statements, which
may include, but are not limited to, such factors as the achievability of financial
guidance, success of new product development, unanticipated changes in product demand,
increased competition, downturns in the Chinese economy, uncompetitive levels of
research and development, and other information detailed from time to time in the
Company’s filings and future filings with the United States Securities and Exchange
Commission. Investors can find many (but not all) of these statements by the use
of words such as "approximates," "believes," "hopes," "expects," "anticipates," "
estimates," "projects," "intends," "plans," "will," "would," "should," "could," "
may" or other similar expressions in this announcement. Statements that are not 
historical facts, including statements about the Company’s beliefs, plans, and expectations,
are forward-looking statements. The forward-looking statements made herein speak
only as of the date of this press release and the Company undertakes no duty to 
update any forward-looking statement to conform the statement to actual results 
or changes in the Company’s expectations except as required by applicable law or
regulation.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [China Pharma Holdings, Inc. Comments on Unusual Market Activity ](http://www.prnasia.com/story/archive/5009503_CN09503_0?rand=184833)